Immuno|Oncology Market

Immuno-Oncology (IO) Market Size to Hit USD 284.29 Billion by 2033

The global immuno-oncology (IO) market size was estimated at USD 43.73 billion in 2023 and is projected to hit around USD 284.29 billion by 2033, growing at a ...

Cancer Immunotherapy Market Size to Hit USD 296.01 Billion by 2033

Cancer Immunotherapy Market Size to Hit USD 296.01 Billion by 2033 · North America dominated the market and accounted for 45.11% share in 2023 ...

Global Oncology Trends 2024: Outlook to 2028 - IQVIA

Cancer medicine spending rose to $223Bn globally in 2023, with 74% focused in the major developed markets (the United States, EU4+UK and Japan), ...

Cancer Immunotherapy Market Size & Share Report, 2030

The global cancer immunotherapy market size was estimated at USD 125.69 billion in 2023 and is projected to grow at a CAGR of 8.3% from 2024 to 2030.

Immuno-Oncology (Io) Market Size, Value, & Industry Trends By 2030

Immuno-Oncology (IO) Market was USD 28.10 billion in 2022 and is expected to reach USD 156.05 billion by 2030, growing at a CAGR of 23.9% during the ...

Immuno-Oncology Landscape - Cancer Research Institute

Landscape of Immuno-Oncology Drug Development. With an unprecedented number of new investigational agents and companies in immuno-oncology (IO), it has been ...

Oncology Market Size, Share, Growth | CAGR of 12%

Oncology Market size is expected to be worth around USD 628 Billion by 2032 from USD 208 Billion in 2022, at a CAGR of 12% (2022-2032).

Oncology Market Size to Reach USD 668.26 Billion by 2034

The oncology market size accounted for USD 225.01 billion in 2024 and is expected to reach over USD 668.26 billion by 2034, at a CAGR of 11.5%.

Immuno-oncology market set to grow in billions, but access ...

The immuno-oncology market is forecasted to grow to over $150 billion by 2028, based on a recent GlobalData webinar.

Global Immuno-oncology Market Projected at $ 396 Billion by 2034 ...

Global Immuno-oncology Market Global Immuno-oncology Market Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Immuno-oncology Market" ...

Oncology Market Size USD 842.6 Billion by 2032

The Oncology market is projected to grow from USD 225.8 Billion in 2023 to USD 842.6 Billion by 2032, at a CAGR of 15.8% during the forecast period.

Oncology Drugs - Worldwide | Statista Market Forecast

The Oncology Drugs market worldwide is projected to grow by 6.66% (2024-2029) resulting in a market volume of US$268.00bn in 2029.

Immuno-oncology Drugs Market - Price, Size, Share & Growth

Immuno-oncology Drugs Market Size and Trends. Global immuno-oncology drugs market is estimated to be valued at USD 27.25 Bn in 2024 and is expected to reach USD ...

Immuno-Oncology Market - Thematic Intelligence - GlobalData

Immuno Oncology Market Thematic Intelligence Overview. The immuno-oncology (IO) market size was valued at $48 billion in 2022 and is expected to ...

Oncology Drugs Market Size, Share & Growth | Statistics [2032]

The global oncology drugs market size is projected to grow from $220.80 billion in 2024 to $518.25 billion by 2032, at a CAGR of 11.3%

New dynamics of the pharmaceutical oncology market - PwC

We believe that answering the following five questions will help companies focus their efforts amid a changing and dynamic environment.

Value and the Oncology Market - NCBI

A panel of expert speakers on pricing for oncology therapies and the economic market in cancer care.

Delivering innovation: 2020 oncology market outlook

2020 oncology market outlook. At the dawn of a new decade, we take stock of advances and unmet needs in the oncology pharmaceutical market. What will it take ...

The immuno-oncology market – segments, challenges and trends

IO agents available in the market with the strongest performance are PD-1 checkpoint inhibitors. PD-L1 checkpoint inhibitors rank second in ...

Global Immuno-oncology Market: Industry Analysis & Forecast

PMR's study on the immuno-oncology market offers information divided into four important segments-therapy type, therapeutic area, end user, and region.